dQ&A's latest diabetes research includes two presentations from our team at ATTD 2026, one of the world's leading stages for diabetes advancements.
This article reports results of a survey of patients and health care providers regarding their experiences of and challenges with the use of basal insulin.
Our research finds Mounjaro patients report health benefits but face confusion and frustration during therapy initiation.
We are excited to announce that the dQ&A team presented eight abstracts at the Advanced Technologies and Treatments for Diabetes (ATTD) 2023 conference.
dQ&A’s Trevor Bell publishes research in Current Diabetes Reports, offering insights into the critical role psychosocial issues play in diabetes management.
Our semi-annual study of digital health apps in diabetes, known as “DHx” (Digital Health Experience), finds broad variation in patient satisfaction.
We're proud to share Evelyn Cox’s EASD 2022 abstract revealing mental-health disparities among Europeans with diabetes by nationality, gender, and age.
Our T2 Insulin Insights is a semi-annual Research Service that explores the lived experience of people with type 2 diabetes who take insulin.
A national dQ&A survey of over 5,000 people with diabetes found wide variation in grocery store quality, with Aldi, Publix, Costco, H-E-B, and Hy-Vee rated highest.
